Bibliography
- Helliwell RJ, Adams LF, Mitchell MD. Prostaglandin synthases: recent developments and a novel hypothesis. Prostaglandins Leukot Essent Fatty Acids 2004;70:101-13
- Nomura T, Lu R, Pucci ML, Schuster VL. The two-step model of prostaglandin signal termination: in vitro reconstitution with the prostaglandin transporter and prostaglandin 15 dehydrogenase. Mol Pharmacol 2004;65:973-8
- Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999;79:1193-226
- Kanai N, Lu R, Satriano JA, et al. Identification and characterization of a prostaglandin transporter. Science 1995;268:866-9
- Itoh S, Lu R, Bao Y, et al. Structural determinants of substrates for the prostaglandin transporter pgt. Mol pharmacol 1996;50:738-42
- Schuster VL. Molecular mechanisms of prostaglandin transport. Annu Rev Physiol 1998;60:221-42
- Schuster VL. Prostaglandin transport. Prostaglandins Other Lipid Mediat 2002;68-69:633-47
- Shirasaka Y, Shichiri M, Kasai T, et al. A role of prostaglandin transporter in regulating PGE2 release from human bronchial epithelial BEAS-2B cells in reponse to LPS. J Endocrinol 2013;217:265-74
- Chi Y, Khersonsky SM, Chang YT, Schuster VL. Identification of a new class of prostaglandin transporter inhibitors and characterization of their biological effects on prostaglandin e2 transport. J Pharmacol Exp Ther 2006;316:1346-50
- Chi Y, Min J, Jasmin JF, et al. Development of a high-affinity inhibitor of the prostaglandin transporter. J Pharmacol Exp Ther 2011;339:633-41
- Kimple ME, Neuman JC, Linnemann AK, Casey PJ. Inhibitory g proteins and their receptors: Emerging therapeutic targets for obesity and diabetes. Exp Mol Med 2014;46:e102
- Carter R, Mouralidarane A, Ray S, et al. Recent advancements in drug treatment of obesity. Clin Med 2012;12:456-60
- Holes-Lewis KA, Malcolm R, O’Neil PM. Pharmacotherapy of obesity: Clinical treatments and considerations. Am J Med Sci 2013;345:284-8
- Khan SA, Ali A. Unraveling the complex relationship triad between lipids, obesity, and inflammation. Mediators Inflamm 2014;2014:502749
- Kolditz CI, Langin D. Adipose tissue lipolysis. Curr Opin Clin Nutr Metab Care 2010;13:377-81
- Nigam SK, Bush KT, Martovetsky G, et al. The organic anion transporter (oat) family: A systems biology perspective. Physiol Rev 2015;95:83-123
- Humbert M, Lau EM, Montani D, et al. Advances in therapeutic interventions for patients with pulmonary arterial hypertension. Circulation 2014;130:2189-208
- Patel BB, Feng Y, Cheng-Lai A. Pulmonary arterial hypertension: a review in pharmacotherapy. Cardiol Rev 2015;23:33-51
- Benza RL, Gomberg-Maitland M, Miller DP, et al. The reveal registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension. Chest 2012;141:354-62
- Seferian A, Simonneau G. Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow? Eur Respir Rev 2013;22:217-26
- Schuster VL, Chi Y, Wasmuth A, et al. Prostaglandin transporter inhibitors and uses thereof. WO037610A1;2011
- Meanwell NA. Synopsis of some recent tactical application of bioisosteres in drug design. J Med Chem 2011;54:2529-91
- Colvin KL, Yeager ME. Animal models of pulmonary hypertension: matching disease mechanisms to etiology of the human disease. J Pulm Respir Med 2014;4:pii.198
- Valdivia E, Lalich JJ, Hayashi Y, Sonnad J. Alterations in pulmonary alveoli after a single injection of monocrotaline. Arch Pathol 1967;84:64-7
- Lutz TA, Woods SC. Current protocols in pharmacology. In: SJ Enna (editor-in-chief) Overview of animal models of obesity. Curr Protoc Pharmacol. 2012. Chapter 5:Unit 5.61
- Gomez-Arroyo J, Saleem SJ, Mizuno S, et al. A brief overview of mouse models of pulmonary arterial hypertension: Problems and prospects. Am J Physiol Lung Cell Mol Physiol 2012;302:L977-91
- Gomez-Arroyo JG, Farkas L, Alhussaini AA, et al. The monocrotaline model of pulmonary hypertension in perspective. Am J Physiol Lung Cell Mol Physiol 2012;302:L363-9
- Topper JN, Cai J, Stavrakis G, et al. Human prostaglandin transporter gene (hpgt) is regulated by fluid mechanical stimuli in cultured endothelial cells and expressed in vascular endothelium in vivo. Circulation 1998;98:2396-403